Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Dopamine agonists like pramipexole and ropinirole can cause reversible hair loss.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

The new nitric oxide delivery system may effectively treat hair loss by improving hair follicle health and reducing inflammation.

Ginsenoside Rg3 from Panax ginseng can lighten skin by reducing melanin production.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

NDRG1 protein helps infantile hemangioma, a common infant tumor, to grow, and its mismanagement by FOXO1 protein plays a big role in causing the tumor.

GDNF signaling helps in hair growth and skin healing after a wound.

Ginsenoside Rb1 may help remodel hypertrophic scars effectively at a dose of 0.56 mg.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

Glibenclamide slows breast cancer cell growth by stopping cell division.

A protein called FERONIA helps control root hair growth in response to cold and low nitrogen by activating nutrient-sensing pathways in a plant called Arabidopsis.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Progesterone reduces anxiety and depression in female mice by increasing BDNF in the brain, needing 5α-reduction and estradiol.

Blocking the mineralocorticoid receptor can help treat skin thinning caused by steroids.

Ginsenoside Rg3 may help hair growth by increasing a growth-related protein in hair cells.

New drugs like clonidine and prazosin show promise for treating high blood pressure despite some side effects.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Treating Netherton syndrome with growth hormone and dupilumab improves growth safely.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Geranium sibiricum may help manage diabetic complications by inhibiting a key enzyme.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

RE-ORGA, a Korean herb extract, may help prevent hair loss.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.